Glutamate and Psychosis Risk

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|4|466-478

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.4, 2012-02, pp. : 466-478

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Ultra High Risk Approach to Define Psychosis Risk

By  

Current Pharmaceutical Design, Vol. 18, Iss. 4, 2012-02 ,pp. : 346-350

Bentham Science Publishers

Access to resources Recommend Favorite

Gestational Influenza Increases the Risk of Psychosis in Adults

By  

Medicinal Chemistry, Vol. 11, Iss. 7, 2015-01 ,pp. : 676-682

Bentham Science Publishers

Access to resources Recommend Favorite

Neurocognition in the Psychosis Risk Syndrome: A Quantitative and Qualitative Review

By  

Current Pharmaceutical Design, Vol. 18, Iss. 4, 2012-02 ,pp. : 399-415

Bentham Science Publishers

Access to resources Recommend Favorite

Psychoeducation in Subjects at Elevated Risk for Psychosis - A Critical Review

By  

Current Pharmaceutical Design, Vol. 18, Iss. 4, 2012-02 ,pp. : 566-569

Bentham Science Publishers

Access to resources Recommend Favorite

Dopamine-Glutamate Interaction and Antipsychotics Mechanism of Action: Implication for New Pharmacological Strategies in Psychosis

By  

Current Pharmaceutical Design, Vol. 11, Iss. 27, 2005-10 ,pp. : 3561-3594

Bentham Science Publishers

Access to resources Recommend Favorite